Research InterestsDr. Rus specializes in the diagnosis and management of multiple sclerosis. He sees patients one day a week and also runs a research laboratory. In addtion, Dr. Rus participates and directs clinical trials in investigating new drug therapies for Multiple Sclerosis. Dr. Rus’s specific laboratory research lies in understanding the mechanisms of oligodendrocyte cell death through a process called apoptosis. Oligodendorcytes are special cells in the brain that make myelin. Myelin is wrapped around nerve fibers and helps increase the speed of nerve transmission. It is felt that injury or death of oligodendrocytes contributes to the MS disease process. In MS there are periods of time when the disease is most active. The hallmark of active MS is inflammation. During the active, inflammatory phase of multiple sclerosis, oligodendrocytes undergo apoptosis (or cell death). Therefore there are less oligodendrocytes, lessening ability to make myelin. This can contribute to the demyelinating process and the accumulation of disability. Dr. Rus research is funded by the National Institute of Health and the National Multiple Sclerosis Society. He has published over 90 papers and book chapters. Publications
|
